Lanean...
Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient Population
Multiple studies have demonstrated that obesity is associated with a worse outcome for all breast cancer subtypes and that obese breast cancer patients do not respond as well as normal weight patients to aromatase inhibitor treatment and chemotherapy. While a number of mechanisms have been proposed...
Gorde:
| Argitaratua izan da: | Curr Pharmacol Rep |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591549/ https://ncbi.nlm.nih.gov/pubmed/26442202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-015-0041-y |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|